OPA1 in cardiovascular health and disease

Current Drug Targets

Volumn 16, Issue 8, 2015, Pages 912-920

  Burke, Niall ^a   Hall, Andrew R ^a   Hausenloy, Derek J ^a,b,c  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b DUKE NUS MEDICAL SCHOOL   (Singapore)

^c DEPARTMENT OF CARDIOLOGY   (Singapore)

Author keywords

Cardiovascular disease; Fission; Fusion; Mitochondrial morphology; OPA1

Indexed keywords

1,10 PHENANTHROLINE; DYNAMIN I; MEMBRANE FUSION PROTEIN; MITOCHONDRIAL PERMEABILITY TRANSITION PORE; MITOFUSIN 1; MITOFUSIN 2; OPTIC ATROPHY PROTEIN 1; REACTIVE OXYGEN METABOLITE; UNCLASSIFIED DRUG; GUANOSINE TRIPHOSPHATASE; OPA1 PROTEIN, HUMAN;

ALTERNATIVE RNA SPLICING; APOPTOSIS; ARTICLE; CARDIOVASCULAR DISEASE; CELL DIFFERENTIATION; DIABETES MELLITUS; DOWN REGULATION; HEART FAILURE; HEART LEFT VENTRICLE HYPERTROPHY; HEART MUSCLE CELL; HUMAN; HYPOXIA; MEMBRANE DEPOLARIZATION; METABOLIC DISORDER; MITOCHONDRIAL ENERGY TRANSFER; MITOCHONDRIAL MEMBRANE POTENTIAL; MITOCHONDRIAL RESPIRATION; NONHUMAN; OXIDATIVE PHOSPHORYLATION; PLEIOTROPY; PROTEIN CLEAVAGE; PROTEIN PROCESSING; REPERFUSION INJURY; RESPIRATORY CHAIN; RNA INTERFERENCE; ANIMAL; ANTAGONISTS AND INHIBITORS; CARDIOVASCULAR DISEASES; METABOLIC DISEASES; METABOLISM; MITOCHONDRION; MOLECULARLY TARGETED THERAPY; PHYSIOLOGY;

ANIMALS; CARDIOVASCULAR DISEASES; DOWN-REGULATION; GTP PHOSPHOHYDROLASES; HUMANS; METABOLIC DISEASES; MITOCHONDRIA; MOLECULAR TARGETED THERAPY;

EID: 84940950108     PISSN: 13894501     EISSN: 18735592     Source Type: Journal    
DOI: 10.2174/1389450116666150102113648     Document Type: Article

References (70)

1. Rizzuto R, De Stefani D, Raffaello A, Mammucari C. Mitochondria as sensors and regulators of calcium signalling. Nat Rev Mol Cell Biol 2012; 13(9): 566-78.
2. Balaban RS, Nemoto S, Finkel T. Mitochondria, oxidants, and aging. Cell 2005; 120(4): 483-95.
3. Muller F. The nature and mechanism of superoxide production by the electron transport chain: Its relevance to aging. J Am Aging Assoc 2000; 23(4): 227-53.
4. Arciuch AVG, Elguero ME, Poderoso JJ, Carreras MC. Mitochondrial regulation of cell cycle and proliferation. Antioxid Redox Signal 2012; 16(10): 1150-80.
5. Mandal S, Guptan P, Owusu-Ansah E, Banerjee U. Mitochondrial regulation of cell cycle progression during development as revealed by the tenured mutation in Drosophila. Dev Cell 2005; 9(6): 843- 54.
6. Yang J, Liu X, Bhalla K, et al. Prevention of apoptosis by Bcl-2: release of cytochrome c from mitochondria blocked. Science 1997; 275(5303): 1129-32.
7. Ikeda Y, Shirakabe A, Brady C, Zablocki D, Ohishi M, Sadoshima J. Molecular mechanisms mediating mitochondrial dynamics and mitophagy and their functional roles in the cardiovascular system. J Mol Cell Cardiol 2014.
8. Hall AR, Burke N, Dongworth RK, Hausenloy DJ. Mitochondrial fusion and fission proteins: novel therapeutic targets for combating cardiovascular disease. Br J Pharmacol 2014; 171(8): 1890-906.
9. Belenguer P, Pellegrini L. The dynamin GTPase OPA1: more than mitochondria? Biochim Biophys Acta 2013;1833(1): 176-83.
10. Liesa M, Palacín M, Zorzano A. Mitochondrial dynamics in mammalian health and disease. Physiol Rev 2009; 89(3): 799-845.
11. Alavi MV, Fuhrmann N. Dominant optic atrophy, OPA1, and mitochondrial quality control: understanding mitochondrial network dynamics. Mol Neurodegener 2013; 8: 32.
12. KJER P. Infantile optic atrophy with dominant mode of inheritance: a clinical and genetic study of 19 Danish families. Acta Ophthalmol Suppl 1959; 164(Supp 54): 1-147.
13. Kjer B, Eiberg H, Kjer P, Rosenberg T. Dominant optic atrophy mapped to chromosome 3q region. II. Clinical and epidemiological aspects. Acta Ophthalmol Scand 1996; 74(1): 3-7.
14. Delettre C, Lenaers G, Griffoin JM, et al. Nuclear gene OPA1, encoding a mitochondrial dynamin-related protein, is mutated in dominant optic atrophy. Nat Genet 2000; 26(2): 207-10.
15. Alexander C, Votruba M, Pesch UE, et al. OPA1, encoding a dynamin- related GTPase, is mutated in autosomal dominant optic atrophy linked to chromosome 3q28. Nat Genet 2000; 26(2): 211-5.
16. Delettre C, Griffoin JM, Kaplan J, et al. Mutation spectrum and splicing variants in the OPA1 gene. Hum Genet 2001; 109(6): 584- 91.
17. Olichon A, Emorine LJ, Descoins E, et al. The human dynaminrelated protein OPA1 is anchored to the mitochondrial inner membrane facing the inter-membrane space. FEBS Lett 2002; 523(1-3): 171-6.
18. Satoh M, Hamamoto T, Seo N, Kagawa Y, Endo H. Differential sublocalization of the dynamin-related protein OPA1 isoforms in mitochondria. Biochem Biophys Res Commun 2003; 300(2): 482- 93.
19. Anand R, Wai T, Baker MJ, et al. The i-AAA protease YME1L and OMA1 cleave OPA1 to balance mitochondrial fusion and fission. J Cell Biol 2014; 204(6): 919-29.
20. Baker MJ, Lampe PA, Stojanovski D, et al. Stress-induced OMA1 activation and autocatalytic turnover regulate OPA1-dependent mitochondrial dynamics. EMBO J 2014; 33(6): 578-93.
21. Song Z, Chen H, Fiket M, Alexander C, Chan DC. OPA1 processing controls mitochondrial fusion and is regulated by mRNA splicing, membrane potential, and Yme1L. J Cell Biol 2007; 178(5): 749-55.
22. Griparic L, Kanazawa T, van der Bliek AM. Regulation of the mitochondrial dynamin-like protein Opa1 by proteolytic cleavage. J Cell Biol 2007; 178(5): 757-64.
23. McBride H, Soubannier V. Mitochondrial function: OMA1 and OPA1, the grandmasters of mitochondrial health. Curr Biol 2010; 20(6): R274-6.
24. Chan DC. Fusion and fission: interlinked processes critical for mitochondrial health. Annu Rev Genet 2012; 46: 265-87.
25. Pellegrini L, Scorrano L. A cut short to death: Parl and Opa1 in the regulation of mitochondrial morphology and apoptosis. Cell Death Differ 2007; 14(7): 1275-84.
26. Szklarz SLK, Scorrano L. The antiapoptotic OPA1/Parl couple participates in mitochondrial adaptation to heat shock. Biochim Biophys Acta 2012; 1817(10): 1886-93.
27. Cipolat S, Rudka T, Hartmann D, et al. Mitochondrial rhomboid PARL regulates cytochrome c release during apoptosis via OPA1- dependent cristae remodeling. Cell 2006; 126(1): 163-75.
28. Jiang X, Jiang H, Shen Z, Wang X. Activation of mitochondrial protease OMA1 by Bax and Bak promotes cytochrome c release during apoptosis. Proc Natl Acad Sci USA 2014; 111(41): 14782-7.
29. Zhang K, Li H, Song Z. Membrane depolarization activates the mitochondrial protease OMA1 by stimulating self-cleavage. EMBO Rep 2014; 15(5): 576-85.
30. Rainbolt TK, Saunders JM, Wiseman RL. YME1L degradation reduces mitochondrial proteolytic capacity during oxidative stress. EMBO Rep 2015; 16(1), 97-106.
31. Merkwirth C, Dargazanli S, Tatsuta T, et al. Prohibitins control cell proliferation and apoptosis by regulating OPA1-dependent cristae morphogenesis in mitochondria. Genes Dev 2008; 22(4): 476-88.
32. Sood A, Jeyaraju DV, Prudent J, et al. A Mitofusin-2-dependent inactivating cleavage of Opa1 links changes in mitochondria cristae and ER contacts in the postprandial liver. Proc Natl Acad Sci USA 2014; 111(45): 16017-22.
33. Makino A, Suarez J, Gawlowski T, Han W, Wang H, Scott BT, et al. Regulation of mitochondrial morphology and function by OGlcNAcylation in neonatal cardiac myocytes. Am J Physiol Regul Integr Comp Physiol 2011; 300(6): R1296-302.
34. Samant SA, Zhang HJ, Hong Z, et al. SIRT3 deacetylates and activates OPA1 to regulate mitochondrial dynamics during stress. Mol Cell Biol 2014; 34(5): 807-19.
35. Norton M, Ng AC, Baird S, et al. ROMO1 is an essential redoxdependent regulator of mitochondrial dynamics. Sci Signal 2014; 7(310): ra10.
36. Semenzato M, Scorrano L. O ROM(e)O1, ROM(e)O1, wherefore art thou ROM(e)O1? Sci Signal 2014; 7(310): pe2.
37. An HJ, Shin H, Jo SG, et al. The survival effect of mitochondrial Higd-1a is associated with suppression of cytochrome C release and prevention of caspase activation. Biochim Biophys Acta 2011; 1813(12): 2088-98.
38. An HJ, Cho G, Lee JO, Paik SG, Kim YS, Lee H. Higd-1a interacts with Opa1 and is required for the morphological and functional integrity of mitochondria. Proc Natl Acad Sci USA 2013; 110(32): 13014-9.
39. Malka F, Guillery O, Cifuentes-Diaz C, et al. Separate fusion of outer and inner mitochondrial membranes. EMBO Rep 2005; 6(9): 853-9.
40. Griparic L, van der Wel NN, Orozco IJ, Peters PJ, van der Bliek AM. Loss of the intermembrane space protein Mgm1/OPA1 induces swelling and localized constrictions along the lengths of mitochondria. J Biol Chem 2004; 279(18): 18792-8.
41. Olichon A, Baricault L, Gas N, et al. Loss of OPA1 perturbates the mitochondrial inner membrane structure and integrity, leading to cytochrome c release and apoptosis. J Biol Chem 2003; 278(10): 7743-6.
42. Cipolat S, Martins de Brito O, Dal Zilio B, Scorrano L. OPA1 requires mitofusin 1 to promote mitochondrial fusion. Proc Natl Acad Sci USA 2004; 101(45): 15927-32.
43. Twig G, Elorza A, Molina AJ, et al. Fission and selective fusion govern mitochondrial segregation and elimination by autophagy. EMBO J 2008; 27(2): 433-46.
44. MacVicar TD, Lane JD. Impaired OMA1-dependent cleavage of OPA1 and reduced DRP1 fission activity combine to prevent mitophagy in cells that are dependent on oxidative phosphorylation. J Cell Sci 2014; 127(Pt 10): 2313-25.
45. Mishra P, Carelli V, Manfredi G, Chan DC. Proteolytic cleavage of Opa1 stimulates mitochondrial inner membrane fusion and couples fusion to oxidative phosphorylation. Cell Metab 2014; 19(4): 630- 41.
46. Frezza C, Cipolat S, Martins de Brito O, et al. OPA1 controls apoptotic cristae remodeling independently from mitochondrial fusion. Cell 2006; 126(1): 177-89.
47. Scorrano L, Ashiya M, Buttle K, et al. A distinct pathway remodels mitochondrial cristae and mobilizes cytochrome c during apoptosis. Dev Cell 2002; 2(1): 55-67.
48. Lenaz G, Genova ML. Kinetics of integrated electron transfer in the mitochondrial respiratory chain: random collisions vs. solid state electron channeling. Am J Physiol Cell Physiol 2007; 292(4): C1221-39.
49. Cogliati S, Frezza C, Soriano ME, et al. Mitochondrial cristae shape determines respiratory chain supercomplexes assembly and respiratory efficiency. Cell 2013; 155(1): 160-71.
50. Chen L, Gong Q, Stice JP, Knowlton AA. Mitochondrial OPA1, apoptosis, and heart failure. Cardiovasc Res 2009; 84(1): 91-9.
51. Chen L, Liu T, Tran A, et al. OPA1 mutation and late-onset cardiomyopathy: mitochondrial dysfunction and mtDNA instability. J Am Heart Assoc 2012; 1(5): e003012.
52. Ong SB, Subrayan S, Lim SY, Yellon DM, Davidson SM, Hausenloy DJ. Inhibiting mitochondrial fission protects the heart against ischemia/reperfusion injury. Circulation 2010; 121(18): 2012-22.
53. Din S, Mason M, Völkers M, et al. Pim-1 preserves mitochondrial morphology by inhibiting dynamin-related protein 1 translocation. Proc Natl Acad Sci USA 2013; 110(15): 5969-74.
54. Gao D, Zhang L, Dhillon R, Hong TT, Shaw RM, Zhu J. Dynasore protects mitochondria and improves cardiac lusitropy in Langendorff perfused mouse heart. PLoS One 2013; 8(4): e60967.
55. Xiao X, Hu Y, Quirós PM, Wei Q, Lopez-Otin C, Dong Z. OMA1 mediates OPA1 proteolysis and mitochondrial fragmentation in experimental models of ischemic kidney injury. Am J Physiol Renal Physiol 2014; 306(11): F1316-26.
56. Piquereau J, Caffin F, Novotova M, et al. Down-regulation of OPA1 alters mouse mitochondrial morphology, PTP function, and cardiac adaptation to pressure overload. Cardiovasc Res 2012; 94(3): 408-17.
57. Tang Y, Mi C, Liu J, Gao F, Long J. Compromised mitochondrial remodeling in compensatory hypertrophied myocardium of spontaneously hypertensive rat. Cardiovasc Pathol 2014; 23(2): 101-6.
58. Davies VJ, Hollins AJ, Piechota MJ, et al. Opa1 deficiency in a mouse model of autosomal dominant optic atrophy impairs mitochondrial morphology, optic nerve structure and visual function. Hum Mol Genet 2007; 16(11): 1307-18.
59. Dorn GW, Clark CF, Eschenbacher WH, et al. MARF and Opa1 control mitochondrial and cardiac function in Drosophila. Circ Res 2011; 108(1): 12-7.
60. Rahn JJ, Stackley KD, Chan SS. Opa1 is required for proper mitochondrial metabolism in early development. PLoS One 2013; 8(3): e59218.
61. Kasahara A, Cipolat S, Chen Y, Dorn GW, Scorrano L. Mitochondrial fusion directs cardiomyocyte differentiation via calcineurin and Notch signaling. Science 2013; 342(6159): 734-7.
62. Yu T, Robotham JL, Yoon Y. Increased production of reactive oxygen species in hyperglycemic conditions requires dynamic change of mitochondrial morphology. Proc Natl Acad Sci USA 2006; 103(8): 2653-8.
63. Williamson CL, Dabkowski ER, Baseler WA, Croston TL, Alway SE, Hollander JM. Enhanced apoptotic propensity in diabetic cardiac mitochondria: influence of subcellular spatial location. Am J Physiol Heart Circ Physiol 2010; 298(2): H633-42.
64. Makino A, Scott BT, Dillmann WH. Mitochondrial fragmentation and superoxide anion production in coronary endothelial cells from a mouse model of type 1 diabetes. Diabetologia 2010; 53(8): 1783- 94.
65. Zorzano A, Liesa M, Palacín M. Role of mitochondrial dynamics proteins in the pathophysiology of obesity and type 2 diabetes. Int J Biochem Cell Biol 2009; 41(10): 1846-54.
66. Parra V, Verdejo HE, Iglewski M, et al. Insulin stimulates mitochondrial fusion and function in cardiomyocytes via the AktmTOR- NFκB-Opa-1 signaling pathway. Diabetes 2014; 63(1): 75- 88.
67. Quirós PM, Ramsay AJ, Sala D, et al. Loss of mitochondrial protease OMA1 alters processing of the GTPase OPA1 and causes obesity and defective thermogenesis in mice. EMBO J 2012; 31(9): 2117-33.
68. Duvezin-Caubet S, Jagasia R, Wagener J, et al. Proteolytic processing of OPA1 links mitochondrial dysfunction to alterations in mitochondrial morphology. J Biol Chem 2006; 281(49): 37972-9.
69. Ehses S, Raschke I, Mancuso G, et al. Regulation of OPA1 processing and mitochondrial fusion by m-AAA protease isoenzymes and OMA1. J Cell Biol 2009; 187(7): 1023-36.
70. Ishihara N, Fujita Y, Oka T, Mihara K. Regulation of mitochondrial morphology through proteolytic cleavage of OPA1. EMBO J 2006; 25(13): 2966-77.